Inflammation, neurodegeneration, imbalance of neurotransmitter systems, oxidative stress and depression are all risk factors for obesity. There is evidence regarding the cross-talk between adipose tissue and the immune system and obese patients may show an alteration of immune functions with major depression, including immune suppression with reduced T-cell and macrophage activity. Obesity is mediated by inflammatory cells such as lymphocytes, macrophages and mast cells which release pro-inflammatory cytokines and chemokines. Obesity-induced leukocyte infiltrations in adipose tissue cause cytokine/chemokine release and inflammation. Here, we report the relationship between obesity, neurological alterations and inflammation.
NikolajczykBSJagannathan-BogdanMDenisGV. The outliers become a stampede as immunometabolism reaches a tipping point. Immunol Rev2012; 249(1):253–75.
2.
SlavichGMIrwinMR. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull2014; 140(3):774–815.
3.
KoutmaniYPolitisPKElkourisMAgrogiannisGKemerliMPatsourisERemboutsikaEKaralisKP. Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: Implications for neuroprotection. Mol Psychiatry2013; 18(3):300–7.
4.
GallagherJPOrozco-CabalLFLiuJShinnick-GallagherP. Synaptic physiology of central CRH system. Eur J Pharmacol2008; 583(2–3):215–25.
5.
KapoorMKapurSMehraSDubeUSharadSSidhuS. Genetic variation in D7S1875 repeat polymorphism of leptin gene is associated with increased risk for depression: A case-control study from India. Depress Anxiety2009; 26(9):791–5.
6.
GrinevichVHarbuzMMaXMJessopDTildersFJLightmanSLAguileraG. Hypothalamic pituitary adrenal axis and immune responses to endotoxin in rats with chronic adjuvant-induced arthritis. Exp Neurol2002; 178(1): 112–23.
7.
SimonsPJvan den PangaartPSAertsJMBoonL. Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol2007; 192(2):289–99.
8.
de HerediaFPGómez-MartínezSMarcosA. Obesity, inflammation and the immune system. Proc Nutr Soc2012; 71(2):332–8.
9.
ChuAJ. Antagonism by bioactive polyphenols against inflammation: A systematic view. Inflamm Allergy Drug Targets2014; 13(1):34–64.
10.
SkurkTKolbHMüller-ScholzeSRöhrigKHaunerHHerderC. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol2005; 152(6):863–8.
11.
DixitNSimonSI. Chemokines, selectins and intracellular calcium flux: Temporal and spatial cues for leukocyte arrest. Front Immunol2012; 3:188.
12.
Gadek-MichalskaATadeuszJRachwalskaPBugajskiJ. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep2013; 65(6): 1655–62.
13.
MonshouwerMWitkampRF. Cytochromes and cytokines: Changes in drug disposition in animals during an acute phase response: A mini-review. Vet Q2000; 22(1):17–20.
NumakawaTRichardsMNakajimaSAdachiNFurutaMOdakaHKunugiH. The role of brain-derived neurotrophic factor in comorbid depression: Possible linkage with steroid hormones, cytokines, and nutrition. Front Psychiatry2014; 5:136.
ZeydaMFarmerDTodoricJAszmannOSpeiserMGyöriGZlabingerGJStulnigTM. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond)2007; 31(9):1420–8.
19.
TateyaSKimFTamoriY. Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne)2013; 4:93.
20.
KaramitopoulouEShoniMTheoharidesTC. Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis. Int J Immunopathol Pharmacol2014; 27(2):213–20.
21.
KritasSKSagginiACerulliG. Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation. J Biol Regul Homeost Agents2014; 28(2): 177–81.
22.
KritasSKSagginiAVarvaraG. Impact of mast cells on the skin. Int J Immunopathol Pharmacol2013; 26(4):855–9.
23.
KritasSKSagginiACerulliG. Asthma and mast cell biology. Eur J Inflamm2014; 12:261–65.
24.
LimJIyerALiuL. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. FASEB J2013; 27(12):4757–67.
25.
MaffioliPFogariED'AngeloAPerroneTDerosaG. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin. Eur J Gastroenterol Hepatol2013; 25(9): 1113–22.
26.
YanYLQiuBHuLJJingXDLiuYJDengSBDuJLSheQ. Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: A systematic review and meta-analysis. Eur J Clin Pharmacol2013; 69(12):2001–9.
27.
BrowningLMKrebsJDMooreCSMishraGDO'ConnellMAJebbSA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab2007; 9(1):70–80.
28.
SpencerMFinlinBSUnalR. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes2013; 2(5):1709–17.
